You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
| Title |
Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
|
|---|---|
| Published in |
Frontiers in oncology, November 2022
|
| DOI | 10.3389/fonc.2022.1081632 |
| Pubmed ID | |
| Authors |
Giulia Pinton, Zhuo Wang, Cecilia Balzano, Sara Missaglia, Daniela Tavian, Renzo Boldorini, Dean A. Fennell, Martin Griffin, Laura Moro |